Chronic erythropoietin treatment enhances endogenous nitric oxide production in rats

References

• Eschbach J W, Egrie J C, Downing M R, Browne J K, Adamson J W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73–8
   PubMed Web of Science ®Google Scholar
• Carlini R, Obialo C I, Rothstein M. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients. Am J Hypertens 1993; 6: 103–7
   PubMed Web of Science ®Google Scholar
• Tepel M, Wischniowski H, Zidek W. Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaneously hypertensive rats. Biochem Biophys Res Commun 1991; 177: 991–7
   Google Scholar
• Heidenreich S, Rahn K H, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991; 39: 259–65
   PubMed Web of Science ®Google Scholar
• Muntzel M, Hannedouche T, Lacour B, Drüeke T. Effect of erythropoietin on hematocrit and blood pressure in normotensive and hypertensive rats. J Am Soc Nephrol 1992; 3: 182–7
   PubMed Web of Science ®Google Scholar
• Carlini R G, Dusso A S, Obialo C I, Alvarez U M, Rothstein M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 1993; 43: 1010–14
   PubMed Web of Science ®Google Scholar
• Caravaca F, Pizarro J L, Arrobas M, Cubero J J, García M C, Perez-Miranda M. Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients. Kidney Int 1994; 45: 845–51
   PubMed Web of Science ®Google Scholar
• Kato K, Mizuno K, Hashimoto S, Okazaki K, Asahi K, Kuriki M, et al. Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue. Life Sci 1994; 54: 253–9
   Google Scholar
• Martin J, Moncada S. Blood pressure, erythropoietin, and nitric oxide. Lancet 1988; 1: 644
   PubMed Web of Science ®Google Scholar
• Marsden P A, Goligorsky M S, Brenner B M. Endothelial cell biology in relation to current concepts of vessel wall structure and function. J Am Soc Nephrol 1991; 1: 931–48
   Google Scholar
• Moncada S, Higgs A. Mechanisms of disease: the L-arginine—nitric oxide pathway. N Engl J Med 1993; 329: 2002–12
   PubMed Web of Science ®Google Scholar
• Wilcox C S, Deng X, Doll A H, Snellen H, Welch W J. Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia. Kidney Int 1993; 44: 430–5
   PubMed Web of Science ®Google Scholar
• Jia L, Bonaventura C, Bonaventura J, Stamler J S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature (London) 1996; 380: 221–6
   PubMed Web of Science ®Google Scholar
• Wennmalm Å, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, et al. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993; 73: 1121–7
   PubMed Web of Science ®Google Scholar
• Bank N, Aynedjian H S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993; 43: 1306–12
   PubMed Web of Science ®Google Scholar
• Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278–81
   PubMed Web of Science ®Google Scholar
• Fujihara C K, Michellazzo S M, DeNucci G, Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 1994; 266, (Renal Fluid Electrolyte Physiol 35): F697-F705
   Google Scholar
• Grisham M B, Specian R D, Zimmerman T E. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994; 271: 1114–21
   PubMed Web of Science ®Google Scholar
• Tsukahara H, Miura M, Tsuchida S, Hata I, Hata K, Yamamoto K, et al. Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats. Am J Physiol 1996; 270, (Endocrinol Metab 33): E840-E845
   Google Scholar
• Misko T P, Moore W M, Kasten T P, Nickols G A, Corbett J A, Tilton R G, et al. Selective inhibition of the inducible nitric oxide synthase by amino-guanidine. Eur J Pharmacol 1993; 233: 119–25
   PubMed Web of Science ®Google Scholar
• Joly G A, Ayres M, Chelly F, Kilbourn R G. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem Biophys Res Commun 1994; 199: 147–54
   Google Scholar
• Takita M, Oda Y, Kigoshi S, Muramatsu I. Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats. Pharmacol Biochem Behav 1995; 50: 225–32
   PubMed Web of Science ®Google Scholar
• Ranjan V, Xiao Z, Diamond S L. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol 1995; 269, (Heart Circ Physiol 38): H550-H555
   Google Scholar
• Korenaga R, Ando J, Tsuboi H, Yang W, Sakuma I, Toyo-Oka T, et al. Laminar flow stimulates ATP- and shear stress-dependent nitric oxide production in cultured bovine endothelial cells. Biochem Biophys Res Commun 1994; 198: 213–19
   PubMedGoogle Scholar
• Sessa W C, Pritchard K, Seyedi N, Wang J, Hintze T H. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994; 74: 349–53
   PubMed Web of Science ®Google Scholar
• Poston L, Taylor P D. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 1995; 88: 245–55
   Web of Science ®Google Scholar